Nico Conorozzo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6939 Erie Rd, Derby, NY 14047 Phone: 716-947-5066 |
Mr. Cory Joseph Coleman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6939 Erie Rd, Derby, NY 14047 Phone: 716-947-5066 |
Mr. William G Youngs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6914 Erie Rd, Derby, NY 14047 Phone: 716-947-4067 Fax: 855-331-9048 |
Mr. Alan Joseph Sailer, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6939 Erie Rd, Derby, NY 14047 Phone: 716-947-5066 Fax: 716-947-0618 |
Denise Clouse, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6939 Erie Rd, Derby, NY 14047 Phone: 716-947-5066 |
Joyce Kryszak Tischler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6939 Erie Rd, Derby, NY 14047 Phone: 716-947-5066 |
Mr. Michael Warren Fancher, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6914 Erie Rd, Derby, NY 14047 Phone: 716-947-4067 Fax: 716-947-4103 |
Matthew Guarino Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6939 Erie Rd, Derby, NY 14047 Phone: 716-947-5066 |
News Archive
In a Wall Street Journal opinion piece, U.S. Secretary of the Treasury Timothy Geithner and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, announce the launch of the Global Agriculture and Food Security Program, a fund "to help the world's poorest farmers grow more food and earn more than they do now so they can lift themselves out of hunger and poverty."
Huddersfield researchers have co-published a report on the current knowledge of the effect of Covid-19 on pregnant women and babies.
GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.
Advanced imaging with Positron Emission Tomography (PET) scan shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research recently published online in the Journal of Clinical Oncology.
A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three times the detection rate for genetic changes related to autism spectrum disorders (ASDs) than standard tests. Publishing in the April issue of Pediatrics (and online March 15), the authors urge that CMA become part of the first-line genetic work-up for ASDs.
› Verified 5 days ago